3-Year-Old First to Receive Experimental Gene Therapy for Hunter Syndrome, Surpasses Expectations

Three-year-old Oliver Chu, diagnosed with Hunter syndrome, traveled to the U.K. for an experimental stem-cell gene therapy and received a genetically modified stem-cell infusion in February 2025. He was the fir...























